equityflowunderstand the flow and follow it

EquityFlow › Companies › Gameto

Gameto

Biotech · New York, US · gametogen.com

Developing ovarian cell therapeutics to improve assisted fertility and delay menopause.

In the network

Shares the most investors with (number = shared investors):

Xaira Therapeutics 2

Funding history

Date	Round	Amount
Jan 2022	Series A Gameto, developing ovarian therapeutics to improve fertility and delay menopause, raised a 20M USD round led by Future Ventures.	$20M

Investors

Tap an investor to see what else they have backed.

ARCH Venture Partners Bold Capital Partners Future Ventures Lux Capital

Other companies in Biotech

Imperagen Haga Bioscience Pixelgen Technologies Gallant Chai Discovery SNIPR Biome Cellbox Labs Scope Biosciences GenLumina Actithera NUCLIDIUM Anocca

Other companies in US

Supabase Groq Corgi Triomics Stord Patina Status AI Stilta Nectar Social Synthetic Kalshi Musely

Other companies at Series A stage

&Done &Open 011h 01Health 1000 Satellites 100ms 11x.ai 12 Pharmacy 180° Seguros 1X Technologies 1k Kirana Bazaar 207

Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.